Numinus Wellness to Acquire MedBright AI Investments Inc.

Numinus Wellness Inc. has executed a letter of intent to acquire MedBright AI Investments Inc. via a statutory plan of arrangement, with Numinus issuing approximately 1.86 shares per MedBright share (≈204.7M shares, ~39% pro forma). The deal combines MedBright's AI-enabled clinical solutions with Numinus' clinic operations and psychedelic-assisted therapy expertise to AI-enable mental health clinics across the U.S. and strengthen the combined company's path to revenue growth and positive EBITDA.